Eli Lilly 2004 Annual Report Download - page 55

Download and view the complete annual report

Please find page 55 of the 2004 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

PROXY STATEMENT
5353
Notice of Annual Meeting of Shareholders
April 18, 2005
The annual meeting of shareholders of Eli Lilly and Company will be held at the Lilly Center Auditorium, Lilly
Corporate Center, Indianapolis, Indiana, on Monday, April 18, 2005, at 11:00 a.m. EST (Indianapolis time) for the fol-
lowing purposes:
• to elect four directors of the company to serve three-year terms
• to ratify the appointment by the audit committee of Ernst & Young LLP as principal independent auditors for the
year 2005
• to consider and vote on a shareholder proposal requesting that the board of directors establish a policy of
separating the roles of chairman and chief executive offi cer
• to consider and vote on a shareholder proposal requesting that the board of directors adopt a policy not to limit
importation of prescription drugs
• to consider and vote on a shareholder proposal requesting that the board of directors prepare a report on the
impact of limiting the availability of products to Canadian wholesalers or pharmacies
• to consider and vote on a shareholder proposal requesting that the board of directors prepare a semi-annual report
on the company’s political contributions
• to consider and vote on a shareholder proposal requesting that the board of directors adopt a senior executive
compensation policy based on performance-based stock options
• to consider and vote on a shareholder proposal requesting that the board of directors take specifi c actions to limit
animal testing.
Shareholders of record at the close of business on February 15, 2005, will be entitled to vote at the meeting and any
adjournment of the meeting.
Attendance at the meeting will be limited to shareholders, those holding proxies from shareholders, and invited
guests from the media and fi nancial community. A page at the back of this proxy statement contains an admission
ticket. If you plan to attend the meeting, please bring this ticket with you.
This combined proxy statement and annual report to shareholders and the proxy are being mailed on or about
March 8, 2005.
By order of the board of directors,
Alecia A. DeCoudreaux
Secretary
March 8, 2005
Indianapolis, Indiana